🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Relapsed Adult AML

A Prospective, Multicenter, and Exploratory Study of CMGV in the Treatment of Recurrent Adult AML and MDS-EB-2/Elder AML NCT06329999NA1 site📍 Shanghai Ruijin Hospital · Tests: CMGV Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML/HR-MDS and in Combination With Azacitidine in Previously Untreated HR-MDS NCT06533761Phase 112 sites📍 Duarte📍 Aurora📍 Tampa Stelexis BioSciences · Tests: Eganelisib, Eganelisib in combination with cytarabine, Eganelisib in combination with azacitidine, Azacitadine (AZA) Venetoclax Basket Trial for High Risk Hematologic Malignancies NCT05292664Phase 15 sites📍 San Francisco📍 Aurora📍 Atlanta Andrew E. Place, MD · Tests: Venetoclax, Azacitidine, Cytarabine, Methotrexate, Hydrocortisone Study of Oral PCLX-001 in R/R Acute Myeloid Leukemia NCT06613217Phase 11 site📍 Houston Pacylex Pharmaceuticals · Tests: zelenirstat Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer NCT01137643n/a1 site📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center · Tests: biologic sample preservation procedure, cytology specimen collection procedure Ziftomenib + Mezigdomide in Adolesc. and Adults w/ R/R AML NCT07355335Phase 12 sites📍 Boston📍 Boston Massachusetts General Hospital · Tests: Ziftomenib, Mezigdomide Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies NCT07523555Phase 1, Phase 21 site📍 Shenzhen Beijing Biotech · Tests: Autologous CD19/CD22 dual-target CAR-T module, Autologous CD19/CD20 dual-target CAR-T module, Autologous BCMA/CD19 dual… Study Investigating the Efficacy and Safety of the Addition of Oral-azacitidine to Salvage Treatment by Gilteritinib in Subjects ≥18 Years of Age With Relapsed/Refractory FLT3-mutated Acute Myeloid Leukemia NCT06022003Phase 220 sites📍 Amiens📍 Angers📍 Clamart French Innovative Leukemia Organisation · Tests: AzaCITIDine Oral Tablet, Xospata Personalized NK Cell Therapy in CBT NCT02727803Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Allogeneic Natural Killer Cell Line NK-92, Anti-Thymocyte Globulin, Busulfan, Clofarabine, Cyclophosphamide CD64 CAR T Cell Therapy in Adults With Relapsed and/or Refractory AML NCT07347418Phase 11 site📍 Aurora University of Colorado, Denver · Tests: CD64 CAR T Cells Feasibility and Safety of Donor-derived NK-cell Infusions for Leukemia Relapse Prophylaxis After Hematopoietic Stem Cell Transplantation NCT07256210Phase 21 site📍 Moscow Federal Research Institute of Pediatric Hematology, Oncolog… · Tests: Donor-derived Natural Killer Cell Study Investigating the Safety of CD19 CAR-T Cells in Relapsed/Refractory AML Expressing CD19 NCT06649227Phase 11 site📍 Lille University Hospital, Lille · Tests: CAR-T cell therapy Adapt NK for High Risk Myeloid Diseases as Bridge to Allo HSCT NCT07591649Phase 1, Phase 21 site📍 Minneapolis Masonic Cancer Center, University of Minnesota · Tests: AdaptNK, Fludarabine, Cyclophosphamide, IL-2 Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution NCT06131801n/a6 sites📍 Aurora📍 Atlanta📍 Cincinnati Children's Hospital Medical Center, Cincinnati · Tests: 1. Drug: The Venetoclax PK study is collecting bodily fluid samples (ie., whole blood and optional cerebrospinal fluid)… Venetoclax Combining Chidamide and Azacitidine (VCA) in the Treatment of R/R AML NCT05305859Phase 21 site📍 Xiamen The First Affiliated Hospital of Xiamen University · Tests: venetoclax combining chidamide and azacitidine (VCA) Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL NCT04872478Phase 13 sites📍 Atlanta📍 Atlanta📍 New York Meryx, Inc. · Tests: MRX-2843 Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia NCT06177067Phase 110 sites📍 San Diego📍 Aurora📍 Atlanta St. Jude Children's Research Hospital · Tests: Revumenib, Venetoclax, Azacitidine, intrathecal (IT) chemotherapy, Cytarabine Anti-CD33-CLL1 CAR-T Cells (ICG415) for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia NCT07668557Phase 12 sites📍 Nanchang📍 Nanchang iCell Gene Therapeutics · Tests: Anti-CD33-CLL1 CAR-T cells (ICG415) following lymphodepleting fludarabine and cyclophosphamide CLAG-GO for Patients With Persistent, Relapsed or Refractory AML NCT04050280Phase 21 site📍 Baltimore University of Maryland, Baltimore · Tests: Cladribine, Cytarabine, and Granulocyte-Colony Stimulating Factor with Fractionated Gemtuzumab Ozogamicin (CLAG-GO) Registry of Older Patients With Cancer NCT01137825n/a7 sites📍 Boone📍 Chapel Hill📍 Greenville UNC Lineberger Comprehensive Cancer Center L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML NCT06788756Phase 2, Phase 328 sites📍 Birmingham📍 Miami📍 Augusta Moleculin Biotech, Inc. · Tests: Placebo in combination with Cytarabine Injection, Liposomal Annamycin Injection in combination with Cytarabine Injectio… A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome NCT06501196Phase 113 sites📍 Duarte📍 Los Angeles📍 Palo Alto BlossomHill Therapeutics · Tests: BH-30236, Venetoclax Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia NCT06549790Phase 17 sites📍 Duarte📍 Aurora📍 Newark Nerviano Medical Sciences · Tests: NMS-03597812 Clinical Trial of WBC100 Capsule in Relapsed/Refractory Acute Myeloid Leukemia NCT07014449Phase 11 site📍 Hangzhou Hangzhou Weben Pharma Co., Ltd · Tests: WBC100 QD PLAT-08: A Study Of SC-DARIC33 CAR T Cells In Pediatric And Young Adults With Relapsed Or Refractory CD33+ AML NCT05105152Phase 11 site📍 Seattle Seattle Children's Hospital · Tests: SC-DARIC33 Venetoclax to Augment Epigenetic Modification and Chemotherapy NCT05317403Phase 11 site📍 Milwaukee Medical College of Wisconsin · Tests: Venetoclax, Azacitadine, Vorinostat, Cytarabine, Fludarabine Acute Myeloid Leukemia At Initial Diagnosis and/or Relapse in Children, Teenagers and Young Adults: Molecular Profiling, Multidrug Testing and MSC Interaction Studies NCT05772559n/a28 sites📍 Amiens📍 Angers📍 Besançon Assistance Publique - Hôpitaux de Paris · Tests: Collection of blood sample of bone marrow (cohort 1), Collection of blood sample of bone marrow (cohort 2 and 3) Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia NCT03850574Phase 1, Phase 234 sites📍 Birmingham📍 Duarte📍 Irvine Aptose Biosciences Inc. · Tests: Tuspetinib, Venetoclax Oral Tablet, Azacitidine for Intravenous Infusion Novel Digital Application for Patients With Acute Leukemia NCT06472128NA3 sites📍 Boston📍 Durham📍 Seattle Massachusetts General Hospital · Tests: DREAMLAND, VITAL WELLNESS HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant NCT03326921Phase 11 site📍 Seattle Fred Hutchinson Cancer Center · Tests: CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR, Bone Marrow Aspiration, Biospecimen Collection
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy